Photo

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Photo

Rage in Brazil

Mass protests erupt in the biggest cities of Brazil.  Slideshow 

Photo

The Afghan Army

The many faces of the Afghan National Army, which has taken over security of the country from NATO.  Slideshow 

Sponsored Links

Three more deaths from meningitis outbreak linked to injections

Related Topics

Related Video

Exserohilum rostratum, a type of fungi, is seen in this handout image from the Centres for Disease Control, October 13, 2012. REUTERS/Centres for Disease Control/Handout

Exserohilum rostratum, a type of fungi, is seen in this handout image from the Centres for Disease Control, October 13, 2012.

Credit: Reuters/Centres for Disease Control/Handout

Tue Oct 30, 2012 3:02pm EDT

(Reuters) - Three more patients have died after contracting fungal meningitis from potentially tainted steroid injections supplied by a Massachusetts company, the U.S. Centers for Disease Control and Prevention said on Tuesday, bringing the death toll from the outbreak to 28 nationwide.

Two of the new deaths were in Michigan, which now has reported seven fatalities, and one in Tennessee which has confirmed 11 deaths, the CDC said. The two states have been the hardest hit by the outbreak, first discovered in Tennessee late last month.

The number of cases of fungal meningitis reported across the United States rose to 356 on Tuesday, up nine from Monday, the CDC said. Nineteen of 23 states that received shipments of the steroid have reported cases.

There also are seven reported cases of infections after the steroid was injected into a joint such as a knee, hip, shoulder or elbow, bringing the total number of infections to 363.

The steroid was supplied by New England Compounding Center of Framingham, Massachusetts, which faces multiple investigations. Health authorities have said its facility near Boston failed to make medications in sterile conditions.

(Reporting by Greg McCune; editing by Christopher Wilson)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.